Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT01911780

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01911780
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01911780. Randomized; double masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2016-03-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
Condition
Hypertension
Intervention (Drug)
placebo
Intervention (Drug)
telmisartan + HCTZ
Intervention (Drug)
telmisartan + HCTZ
Intervention (Drug)
amlodipine
Lead sponsor
Boehringer Ingelheim (class: industry)

Record details

Record id
cardio:ct-nct01911780
Content hash
a2100a1490c1bb5a5843660398cc69fc1f2a2b91ec23afa1713b9a05665ef752